SCFAs have bifunctional utility: reducing the secretion of IL-10, an anti-inflammatory cytokine that promotes tumor cell proliferation via immunosuppression, while also increasing NK extracellular vesicle secretion of IFNγ that aids in tumor-killing [41]. This evidence concerns the gene IL10 and neoplasm.